Latest kidney cancer news

24 Jan 2023
Pembrolizumab plus axitinib for metastatic papillary and chromophobe kidney cancer

17 Jan 2023
Real-world survival outcomes of metastatic papillary and clear cell kidney cancer

12 Jan 2023
Long-term data support first-line use of avelumab and axitinib for advanced kidney cancer

12 Jan 2023
Does neoadjuvant therapy improve outcomes in localised kidney cancer?

6 Jan 2023
BioNTech forms alliance with UK government for cancer immunotherapies

3 Jan 2023
CA-125 biomarker for renal medullary carcinoma

16 Dec 2022
Shared decision-making in kidney cancer

15 Dec 2022
Long term outcomes after SABR for kidney cancer tumours

12 Dec 2022
New method enables early detection of cancer

7 Dec 2022
Psychological distress in patients treated for kidney cancer

6 Dec 2022
BMI and outcomes in patients with metastatic kidney cancer treated with first-line TKIs

30 Nov 2022